Gmo Emerging Financials

GMAUX Fund  USD 14.15  0.19  1.32%   
You can make use of fundamental analysis to find out if Gmo Emerging Markets is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We are able to break down and analyze data for five available reported financial drivers for Gmo Emerging Markets, which can be compared to its competitors. The fund experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Gmo Emerging to be traded at $13.73 in 90 days.
  
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

Gmo Emerging Fund Summary

Gmo Emerging competes with Transamerica Emerging, Barings Emerging, Kinetics Market, Massmutual Select, and Templeton Developing. Under normal circumstances at least 80 percent of the funds net assets directly and indirectly in companies tied economically to markets that are not treated as developed markets in the MSCI World Index, with the exception of China . It may also invest In U.S. Treasury fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds. The fund is non-diversified.
Specialization
Diversified Emerging Mkts, Large Value
InstrumentUSA Mutual Fund View All
ExchangeNMFQS Exchange
Business AddressGMO Trust
Mutual Fund FamilyGMO
Mutual Fund CategoryDiversified Emerging Mkts
BenchmarkDow Jones Industrial
Phone617 346 7646
CurrencyUSD - US Dollar

Gmo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Gmo Emerging's current stock value. Our valuation model uses many indicators to compare Gmo Emerging value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gmo Emerging competition to find correlations between indicators driving Gmo Emerging's intrinsic value. More Info.
Gmo Emerging Markets is one of the top funds in annual yield among similar funds. It is rated # 2 fund in net asset among similar funds making up about  1,075,024,043  of Net Asset per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gmo Emerging's earnings, one of the primary drivers of an investment's value.

Gmo Emerging Markets Systematic Risk

Gmo Emerging's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gmo Emerging volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Gmo Emerging Markets correlated with the market. If Beta is less than 0 Gmo Emerging generally moves in the opposite direction as compared to the market. If Gmo Emerging Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gmo Emerging Markets is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gmo Emerging is generally in the same direction as the market. If Beta > 1 Gmo Emerging moves generally in the same direction as, but more than the movement of the benchmark.
Gmo Emerging Markets is rated # 2 fund in net asset among similar funds. Total Asset Under Management (AUM) of Diversified Emerging Mkts category is currently estimated at about 2.23 Billion. Gmo Emerging holds roughly 79.23 Million in net asset claiming about 4% of all funds under Diversified Emerging Mkts category.

Gmo Emerging December 2, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Gmo Emerging help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gmo Emerging Markets. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gmo Emerging Markets based on widely used predictive technical indicators. In general, we focus on analyzing Gmo Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gmo Emerging's daily price indicators and compare them against related drivers.

Other Information on Investing in Gmo Mutual Fund

Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators